WeDaita BioMedAI · Agentic AI

From Target to Candidate —
in One Platform

Agentic AI for Target Discovery and Therapeutic Design. Autonomous AI agents and proprietary models turn one research question into ranked targets and optimized drug candidates.

300+MCP Tools
40+Databases
GraphRAGReasoning
Proprietary AI Models
CLINAVA clinical progression
GENAVA virtual target validation
Long-term vision

Bring Better Medicine to Patients Faster with AI

Stages 1 & 2 are powered by our own BioMedAI platform. Stage 3 is delivered through partners.

Human gate
1

AI Target Discovery

Target Intelligence

  • Integrate public and proprietary biomedical data
  • Leverage proprietary AI models to identify disease-driving targets
  • Deliver evidence-backed, ranked target candidates
BioMedAI Platform
OutputRanked drug targetsFrom disease to the right targets
Human gate
2

AI Drug Design

Drug Intelligence

  • Modality-optimized design: small molecules, antibodies & peptides
  • Hybrid AI: generative AI + physics-based models
  • Experience-driven optimization: improve efficacy, safety & developability
BioMedAI Platform
OutputOptimized drug candidatesFor each target, across modalities
3

Lab & Clinical Validation

Experimental & Clinical Evidence

  • Partner-enabled experimental validation
  • Drug safety, toxicity & PK/PD assessment
  • Clinical evidence and translational validation
Through Partners
OutputLab-validated leadsReady for further development
Experimental results can sharpen your own target and candidate selection  ·  Human gates: scientists review and approve every handoff
Bringing medicine to patients earlier isn’t just about saving time and money — it’s about saving lives.
Proprietary AI models

Decisions you can trace and trust

Clinical progression

CLINAVA™

Predicts how far a target is likely to progress clinically, giving a quantitative basis for choosing which targets to pursue.

Virtual cell

GENAVA™

Simulates gene perturbations in silico to validate a target and trace the biological pathways behind each recommendation.

Validate Drug Targets with AI Precision

See how BioMedAI analyzes biomedical data to identify and validate potential drug targets

  • Integrated analysis from 40+ biomedical databases
  • AI-powered target validation and scoring
  • Comprehensive pathway and interaction insights
  • Evidence-based target recommendations
Stay Ahead

AI Drug Discovery, Delivered Monthly

Get curated insights on AI-driven target identification, therapeutic design, and BioMedAI platform updates — directly to your inbox.

No spam. Unsubscribe at any time. We respect your privacy.

The Team

Built by People Who Have Lived the Problem

Combining deep domain expertise across AI, biology and chemistry in both academia and industry.

Leadership Team
Scientific Experts
The Validation

Ecosystem Recognition & Strategic Support

Selected by leading innovation programs supporting AI and life sciences.

NVIDIA Inception Program

Member of NVIDIA’s global startup program accelerating AI innovation — providing access to the NVIDIA AI ecosystem, technical resources, and industry connections.

awsActivate

Qualified for AWS startup support, cloud credits, and infrastructure resources to accelerate scalable AI platform development.

Harvard Business School Foundry

Selected for entrepreneurial support and founder ecosystem access through Harvard Business School’s innovation programs.

Ready to Accelerate Your Drug Discovery?

BioMedAI is live — start with AI Target Discovery and antibody & protein design today.